Protein & Cell >

2023 , Vol. 14 >Issue 5: 382 - 386

DOI: https://doi.org/10.1093/procel/pwac025

LETTER

Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R

  • Beibei Li 1,2 ,
  • Shuo Han 1,2 ,
  • Mu Wang 1,3 ,
  • Yu Yu 1,2 ,
  • Limin Ma 1 ,
  • Xiaojing Chu 1 ,
  • Qiuxiang Tan , 1,2 ,
  • Qiang Zhao , 1,2,4 ,
  • Beili Wu , 1,2,3,5
Expand
  • 1. CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
  • 2. University of Chinese Academy of Sciences, Beijing 100049, China
  • 3. School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
  • 4. Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China
  • 5. School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, China
qxtan@simm.ac.cn
zhaoq@simm.ac.cn
beiliwu@simm.ac.cn

Accepted date: 27 May 2022

Published date: 15 May 2023

Copyright

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.
Fold

Cite this article

Beibei Li , Shuo Han , Mu Wang , Yu Yu , Limin Ma , Xiaojing Chu , Qiuxiang Tan , Qiang Zhao , Beili Wu . Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R[J]. Protein & Cell, 2023 , 14(5) : 382 -386 . DOI: 10.1093/procel/pwac025

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Abbracchio MP, Burnstock G, Boeynaems JM et al. International Union of Pharmacology LVIII: update on the P2Y G proteincoupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006;58:281–341.

DOI

2
Flock T, Ravarani CNJ, Sun D et al. Universal allosteric mechanism for Gα activation by GPCRs. Nature 2015;524:173–179.

DOI

3
Gao ZG, Hechler B, Besada P et al. Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation. Biochem Pharmacol 2008;75:1341–1347.

DOI

4
Hensch NR, Karim ZA, Pineda J et al. P2Y12 antibody inhibits platelet activity and protects against thrombogenesis. Biochem Biophys Res Commun 2017;493:1069–1074.

DOI

5
Karim ZA, Vemana HP, Alshbool FZ et al. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor. Arterioscler Thromb Vasc Biol 2015;35:637–644.

DOI

6
Kim S, Kunapuli SP. P2Y12 receptor in platelet activation. Platelets 2011;22:56–60.

DOI

7
Koehl A, Hu H, Maeda S et al. Structure of the μ-opioid receptor-Gi protein complex. Nature 2018;558:547–552.

DOI

8
Leon C, Hechler B, Freund M et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 1999;104:1731–1737.

DOI

9
Olsen RHJ, DiBerto JF, English JG et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat Chem Biol 2020;16:841–849.

DOI

10
Qiao A, Han S, Li X et al. Structural basis of Gs and Gi recognition by the human glucagon receptor. Science 2020;367:1346–1352.

DOI

11
Rasmussen SG, DeVree BT, Zou Y et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 2011; 477:549–555.

DOI

12
Weisman GA, Woods LT, Erb L et al. P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential. CNS Neurol Disord Drug Targets 2012;11:722–738.

DOI

13
Zhang D, Gao ZG, Zhang K et al. Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 2015;520:317–321.

DOI

14
Zhang J, Zhang K, Gao ZG et al. Agonist-bound structure of the human P2Y12 receptor. Nature 2014a;509:119–122.

DOI

15
Zhang K, Zhang J, Gao ZG et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 2014b;509:115–118.

DOI

Options
Outlines

/

〈 〉